Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON53107
NL-OMON53107
Recruiting
Not Applicable

Twin cohort for the study of (pre)clinical Inflammatory Bowel Disease in the Netherlands * The TWIN study - The TWIN study for Inflammatory Bowel Disease

Maag-, Darm- en Leverziekten & Laboratorium voor Translationele Immunologie0 sites444 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Maag-, Darm- en Leverziekten & Laboratorium voor Translationele Immunologie
Enrollment
444
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational invasive

Eligibility Criteria

Ages
16 to 99 (—)

Inclusion Criteria

  • •Inclusion criteria for the IBD\-discordant and IBD\-concordant twins or multiples:
  • •\- Born as a sibling of, either a monozygous or dizygous, twin pair or multiplex
  • •\- One or more twin\-siblings or multiples are affected with IBD, i.e. CD, UC or
  • •IBD unspecified (self\-reported diagnosis, to be confirmed during the study by
  • •clinical, endoscopic or histological reports from the treating physician)
  • •\- Age: 16 years and older, In order to be eligible to participate in this
  • •study, a subject must meet all of the following criteria for the unaffected
  • •controls (preferably twins or multiples):
  • •\- None of the siblings of the twin are affected with IBD, i.e. CD, UC or IBD
  • •unspecified

Exclusion Criteria

  • •A potential subject who meets any of the following criteria will be excluded
  • •from participation in this study:
  • •\- No consent to participate in the study.

Investigators

Sponsor
Maag-, Darm- en Leverziekten & Laboratorium voor Translationele Immunologie

Similar Trials

Recruiting
Not Applicable
Twin cohort for the study of (pre)clinical Inflammatory Bowel Disease in the NetherlandsThe TWIN-studyInflammatory Bowel Disease<br />IBD<br />M. Crohn<br />Crohn's disease<br />ziekte van Crohn<br />Ulcerative colitis<br />colitis ulcerosa<br />twin<br />tweeling<br />preklinisch<br />preclinical
NL-OMON23799niversity Medical Center Utrecht444
Active, not recruiting
Not Applicable
A Phase I/II Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171.
EUCTR2014-002841-23-BEAblynx NV53
Active, not recruiting
Not Applicable
A Phase I/II Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171.Respiratory Syncytial Virus Lower Respiratory Tract InfectionMedDRA version: 18.0Level: PTClassification code 10061603Term: Respiratory syncytial virus infectionSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2014-002841-23-PLAblynx NV35
Active, not recruiting
Not Applicable
A Phase I/II Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171.
EUCTR2014-002841-23-EEAblynx NV53
Active, not recruiting
Phase 1
A Phase I/II Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171.
EUCTR2014-002841-23-GBAblynx NV51